Vertex Pharmaceuticals Inc
(BSP:VRTX34)
R$
607.2
(0%)
Market Cap: 616.44 Bil
Enterprise Value: 589.21 Bil
PE Ratio: 29.46
PB Ratio: 6.52
GF Score: 87/100 
Vertex Pharmaceuticals Inc at Citi Global Healthcare Conference Transcript
Dec 03, 2025 / 02:00PM GMT
Release Date Price:
R$580.26
Geoffrey Meacham
Citi Infrastructure Investments LLC - Analyst
Welcome to the second day of the Citi Global Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst. And we're thrilled today to have Vertex Pharmaceuticals. And on stage with me, we have Charlie Wagner, Chief Operation and Financial Officer. We have David Altshuler, who is EVP and CSO and maybe six months from retirement, maybe? Okay, so both legends. So guys, thanks for joining.
Charles Wagner
Vertex Pharmaceuticals Inc - Chief Financial Officer, Executive Vice President
One legend. I'm aspiring.
David Altshuler
Vertex Pharmaceuticals Inc - Executive Vice President, Chief Scientific Officer
You shouldn't say that about yourself, Charlie.
Questions & Answers
Geoffrey Meacham
Citi Infrastructure Investments LLC - Analyst
Let's talk first about JOURNAVX, maybe commercial, and then move over to clinical. So maybe, Charlie, just give us a bit of a status update with the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers